Literature DB >> 22524852

Factors associated with attending the National Cancer Screening Program for liver cancer in Korea.

Dai Keun Noh1, Kui Son Choi, Jae Kwan Jun, Hoo-Yeon Lee, Eun-Cheol Park.   

Abstract

BACKGROUND AND AIMS: The National Cancer Screening Program (NCSP) for liver cancer was initiated in 2003 in Korea. The objective of this study was to evaluate the participation rate of the program and to provide preliminary information on its results based on data collected by the NCSP in 2009.
METHODS: The target population of the NCSP for liver cancer in 2009 was comprised of 373,590 adults aged ≥40 years at high risk for liver cancer. Participation rates and positivity rates were assessed in this population. Multivariate logistic regression analysis was performed to determine the factors associated with participation in the NCSP for liver cancer.
RESULTS: The overall participation rate was 37.9% and 1,126 participants were positive at screening. The highest participation rates were observed in women, those in their 60s, National Health Insurance beneficiaries, and individuals positive for hepatitis B surface antigen. Positivity rates for men, those in their 70s, Medical Aid Program recipients and individuals with liver cirrhosis were the highest in the respective categories of gender, age, health insurance type, and risk factor for liver cancer.
CONCLUSIONS: The participation rates of the NCSP for liver cancer are still low, despite the fact that the program targets a high-risk group much smaller than the general population. Efforts to facilitate participation and to reduce disparities in liver cancer screening among Korean men and women are needed. These results provide essential data for evidence-based strategies for liver cancer control in Korea.

Entities:  

Mesh:

Year:  2012        PMID: 22524852     DOI: 10.7314/apjcp.2012.13.2.731

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Factors associated with alcohol consumption in hepatitis B carriers: a nationwide study in the Republic of Korea.

Authors:  Boyoung Park; Kyu-Won Jung; Chang-Mo Oh; Kui Son Choi; Mina Suh; Jae Kwan Jun
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

2.  Sex differences associated with hepatitis B virus surface antigen seropositivity unwareness in hepatitis B virus surface antigen-positive adults: 2007-2012 Korea National Health and Nutrition Examination Survey.

Authors:  Suk-Yong Jang; Sung-In Jang; Hong-Chul Bae; Jaeyong Shin; Eun-Cheol Park
Journal:  J Prev Med Public Health       Date:  2015-03-16

3.  A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea.

Authors:  Hee Yeon Kim; Chang Wook Kim; Jong Young Choi; Chung-Hwa Park; Chang Don Lee; Hyeon Woo Yim
Journal:  Chin Med J (Engl)       Date:  2016-01-05       Impact factor: 2.628

4.  Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013.

Authors:  Mina Suh; Kui Son Choi; Boyoung Park; Yoon Young Lee; Jae Kwan Jun; Duk-Hyoung Lee; Yeol Kim
Journal:  Cancer Res Treat       Date:  2015-04-15       Impact factor: 4.679

5.  Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.

Authors:  Boyoung Park; Kui Son Choi; Mina Suh; Ji-Yeon Shin; Jae Kwan Jun
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

6.  Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey, 2004-2012.

Authors:  Mina Suh; Kui Son Choi; Yoon Young Lee; Jae Kwan Jun
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

7.  Ten-Year Changes in the Hepatitis B Prevalence in the Birth Cohorts in Korea: Results From Nationally Representative Cross-Sectional Surveys.

Authors:  Boyoung Park; Kyu-Won Jung; Chang-Mo Oh; Kui Son Choi; Mina Suh; Jae Kwan Jun
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.